Christophe Bonny

Christophe Bonny has served as our Chief Scientific Officer since 2016. Dr. Bonny has approximately 20 years’ experience in the field of molecular biology and signaling pathways and 15 years in the field of hit identification to candidate selection. Before joining us, Dr. Bonny served as the Chief Scientific Officer at Bicycle Therapeutics Limited from 2013 to 2016. From 2006 to 2012, Dr. Bonny served as the Chief Scientific Officer of Xigen SA and also served as its President from 2011 to 2012. In 2005, Dr. Bonny received the Pfizer Research Prize. Mr. Bonny holds a Ph.D. in biochemistry and molecular biology from Neuchâtel University.

Christophe Bonny is the Chief Scientific Officer at ENTEROME, based in Europe. With a background in Biotechnology, Christophe Bonny has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.